Literature Recap: October 1-15, 2026
Posted in Papers / Original Research / Human Studies / Editor's Picks / October 1-15, 2026
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
Posted on October 14, 2026
Posted in Papers / Original Research / Human Studies / October 1-15, 2026
Plasma amylin levels in migraine and after erenumab treatment: A REFORM study
Posted on October 14, 2026
Posted in Papers / Original Research / Human Studies / October 1-15, 2026
The MIND study: Design, feasibility, and baseline characteristics of a smartphone-based migraine cohort
Posted on October 14, 2026
Posted in Papers / Reviews / October 1-15, 2026
Headache disorders among Indigenous communities: A scoping review undertaken with knowledge keeper guidance
Posted on October 14, 2026
Posted in Papers / Original Research / Human Studies / October 1-15, 2026
Somatosensory Profiling in Primary Headache Disorders: Examining Interictal, Diagnostic and Headache Frequency related Alterations
Posted on October 14, 2026
Posted in Papers / Original Research / Human Studies / October 1-15, 2026
Identifying potential risk factors for migraine-related vertigo in children
Posted on October 13, 2026
Posted in Papers / Original Research / Human Studies / October 1-15, 2026
Iron-Sensitive MRI Reveals Individual Differences in Pain Modulation Rather Than Categorical Markers in Chronic Pain and Migraine
Posted on October 13, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Fremanezumab for episodic migraine in children and adolescents: the evolving landscape of CGRP-targeted therapies
Posted on October 13, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Science Is a Lot of Fun: How Professor Jes Olesen Made Discoveries in Migraine
Posted on October 13, 2026